Eli Lilly Expects Up to $87 Billion in 2026 Revenue. Here's Why the Stock Still Looks Undervalued.

Eli Lilly's revenue is expected to reach up to $87 billion in 2026, but the stock is still considered undervalued.

Want to stay up to date with the world events at sea or at home?

Explore Navvyx News - the best News app for seafarers.